The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global Hormonal Contraceptive Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.

The global Hormonal Contraceptive market size in 2022 is 16600.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 4.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Hormonal Contraceptive market include Abbvie, Inc (U.S.), Afaxys, Inc. (U.S.), Merck & Co Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), and Bayer AG (Germany). The share of the top 3 players in the Hormonal Contraceptive market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Hormonal Contraceptive market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Combined Oral Contraceptives accounted for XX% of Hormonal Contraceptive market in 2022. Oral share of XX%.

Androgens accounted for XX% of the Hormonal Contraceptive market in 2022. Estrogens accounts for XX%.

For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.

As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.

Key Factors Considered:

COVID-19

The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.

Regional Conflict / Russia-Ukraine War

The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.

Challenges & Opportunities

Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.

With the development of the economy, the improvement of residents' consumption level and the upgrade of consumption structure, the food and beverage industry as a whole has shown a good growth trend. In the future, the production capacity will continue to expand, and the industrial structure will be further improved and optimized.

E-Commerce Growth: The growth of e-commerce has significantly impacted the food and beverage industry. Online grocery shopping and food delivery services have witnessed tremendous growth, especially during the COVID-19 pandemic. Companies have been investing in online platforms and expanding their digital presence to cater to changing consumer preferences.

Clean label and transparency: Consumers are increasingly seeking transparency in food products. Clean label initiatives emphasize the use of natural ingredients, removal of artificial additives, and clear and accurate labeling to provide consumers with more information about the food they consume.

Regions Covered in This Report Are

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Asia Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Latin America

Brazil

Argentina

Mexico

MEA

Saudi Arabia

UAE

Turkey

Some of the Top Key Players:

Abbvie, Inc (U.S.)

Afaxys, Inc. (U.S.)

Merck & Co Inc. (U.S.)

Teva Pharmaceuticals Industries Ltd. (Israel)

Bayer AG (Germany)

Pfizer Inc. (U.S.)

Agile Therapeutics (U.S.)

Cupid Ltd. (India)

Helm AG (Germany)

Church & Dwight Co., Inc (U.S.)

Organon group of companies (U.S.)

Reckitt Benckiser Group PLC (U.K.)

Veru Inc. (U.S.)

Boehringer Ingelheim International GmbH (Germany)

Novartis AG (Switzerland)

Lupin (India)

Glenmark Pharmaceuticals (India)

Product Types Outlook

Combined Oral Contraceptives

Oral

Contraceptives

Implanted Contraceptives

Injected Contraceptives

Intrauterine

Transdermal Patch Vaginal Ring

Application Outlook

Androgens

Estrogens

Progestogens

Antiandrogens

Gonadotropins

Others

Table of Content

1 Study Coverage

1.1 Hormonal Contraceptive Product Introduction

1.2 Global Hormonal Contraceptive Outlook 2018 VS 2023 VS 2029

1.3 United States Hormonal Contraceptive Outlook 2018 VS 2023 VS 2029

1.4 Hormonal Contraceptive Market Size, United States VS Global, 2018-2029

1.4.1 The Market Share of United States Hormonal Contraceptive in Global, 2018-2029

1.4.2 The Growth Rate of Hormonal Contraceptive Market Size, United States VS Global, 2018 VS 2023 VS 2029

1.5 Hormonal Contraceptive Market Dynamics

1.5.1 Hormonal Contraceptive Market Trends

1.5.2 Hormonal Contraceptive Market Drivers

1.5.3 Hormonal Contraceptive Market Challenges

1.5.4 Hormonal Contraceptive Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Coronavirus Disease (COVID-19) Impact on Global

2 Global Hormonal Contraceptive Competitor Landscape by Company

2.1 Global Hormonal Contraceptive Market Size by Company

2.1.1 Top Global Hormonal Contraceptive Player Ranked by Revenue (2023)

2.1.2 Global Hormonal Contraceptive Revenue by Player (2018-2023)

2.2 Global Hormonal Contraceptive Concentration Ratio (CR)

2.2.1 Hormonal Contraceptive Market Concentration Ratio (CR) (2018-2023)

2.2.2 Global Top 3 and Top 6 Largest Players of Hormonal Contraceptive in 2023

2.3 Global Hormonal Contraceptive Business Distribution, Business Type

2.3.1 Global Hormonal Contraceptive Players, Headquarters and Distribution

2.3.2 Players Hormonal Contraceptive Business Type

2.3.3 Date of International Players Enter into Hormonal Contraceptive Market

2.4 Players Mergers & Acquisitions, Expansion Plans

2.5 United States Hormonal Contraceptive Market Size by Company

2.5.1 Top United States Hormonal Contraceptive Player s Ranked by Revenue (2023)

2.5.2 United States Hormonal Contraceptive Revenue by Player (2018-2023)

3 Hormonal Contraceptive Market Segment by Type

3.1 Hormonal Contraceptive Market Segment by Type

3.2 Global Hormonal Contraceptive Market Size by Type

3.3 United States Hormonal Contraceptive Market Size by Type

4 Hormonal Contraceptive Market Segment by Application

4.1 Hormonal Contraceptive Market Segment by Application

4.2 Global Hormonal Contraceptive Market Size by Application

4.3 United States Hormonal Contraceptive Market Size by Application

5 Global Hormonal Contraceptive Market Size by Region

5.1 Global Hormonal Contraceptive Market Size by Region: 2018 VS 2023 VS 2029

5.2 Global Hormonal Contraceptive Market Size in Value by Region (2018-2029)

5.2.1 Global Hormonal Contraceptive Revenue by Region: 2018-2023

5.2.2 Global Hormonal Contraceptive Revenue by Region: 2023-2029

5.3 Global Hormonal Contraceptive Market Size in Volume by Region (2018-2029)

5.3.1 Global Hormonal Contraceptive Volume by Region: 2018-2023

5.3.2 Global Hormonal Contraceptive Volume by Region: 2023-2029

6 Segment in Regional Level & Country Level

6.1 North America

6.1.1 North America Hormonal Contraceptive Market Size YoY Growth 2018-2029

6.1.2 North America Hormonal Contraceptive Market Facts & Figures by Country (2018-2029)

6.1.3 U.S.

6.1.4 Canada

6.2 Asia Pacific

6.2.1 Asia Pacific Hormonal Contraceptive Market Size YoY Growth 2018-2029

6.2.2 Asia Pacific Hormonal Contraceptive Market Facts & Figures by Country (2018-2029)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 Southeast Asia

6.3 Europe

6.3.1 Europe Hormonal Contraceptive Market Size YoY Growth 2018-2029

6.3.2 Europe Hormonal Contraceptive Market Facts & Figures by Country (2018-2029)

6.3.3 Germany

6.3.4 France

6.3.5 UK

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Hormonal Contraceptive Market Size YoY Growth 2018-2029

6.4.2 Latin America Hormonal Contraceptive Market Facts & Figures by Country (2018-2029)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa Hormonal Contraceptive Market Size YoY Growth 2018-2029

6.5.2 Middle East and Africa Hormonal Contraceptive Market Facts & Figures by Country (2018-2029)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

7.1 Abbvie, Inc (U.S.)

7.1.1 Abbvie, Inc (U.S.) Company Details

7.1.2 Description and Business Overview

7.1.3 Hormonal Contraceptive Introduction

7.1.4 Abbvie, Inc (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.1.5 Abbvie, Inc (U.S.) Recent Development

7.2 Afaxys, Inc. (U.S.)

7.2.1 Afaxys, Inc. (U.S.) Company Details

7.2.2 Description and Business Overview

7.2.3 Hormonal Contraceptive Introduction

7.2.4 Afaxys, Inc. (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.2.5 Afaxys, Inc. (U.S.) Recent Development

7.3 Merck & Co Inc. (U.S.)

7.3.1 Merck & Co Inc. (U.S.) Company Details

7.3.2 Description and Business Overview

7.3.3 Hormonal Contraceptive Introduction

7.3.4 Merck & Co Inc. (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.3.5 Merck & Co Inc. (U.S.) Recent Development

7.4 Teva Pharmaceuticals Industries Ltd. (Israel)

7.4.1 Teva Pharmaceuticals Industries Ltd. (Israel) Company Details

7.4.2 Description and Business Overview

7.4.3 Hormonal Contraceptive Introduction

7.4.4 Teva Pharmaceuticals Industries Ltd. (Israel) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.4.5 Teva Pharmaceuticals Industries Ltd. (Israel) Recent Development

7.5 Bayer AG (Germany)

7.5.1 Bayer AG (Germany) Company Details

7.5.2 Description and Business Overview

7.5.3 Hormonal Contraceptive Introduction

7.5.4 Bayer AG (Germany) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.5.5 Bayer AG (Germany) Recent Development

7.6 Pfizer Inc. (U.S.)

7.6.1 Pfizer Inc. (U.S.) Company Details

7.6.2 Description and Business Overview

7.6.3 Hormonal Contraceptive Introduction

7.6.4 Pfizer Inc. (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.6.5 Pfizer Inc. (U.S.) Recent Development

7.7 Agile Therapeutics (U.S.)

7.7.1 Agile Therapeutics (U.S.) Company Details

7.7.2 Description and Business Overview

7.7.3 Hormonal Contraceptive Introduction

7.7.4 Agile Therapeutics (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.7.5 Agile Therapeutics (U.S.) Recent Development

7.8 Cupid Ltd. (India)

7.8.1 Cupid Ltd. (India) Company Details

7.8.2 Description and Business Overview

7.8.3 Hormonal Contraceptive Introduction

7.8.4 Cupid Ltd. (India) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.8.5 Cupid Ltd. (India) Recent Development

7.9 Helm AG (Germany)

7.9.1 Helm AG (Germany) Company Details

7.9.2 Description and Business Overview

7.9.3 Hormonal Contraceptive Introduction

7.9.4 Helm AG (Germany) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.9.5 Helm AG (Germany) Recent Development

7.10 Church & Dwight Co., Inc (U.S.)

7.10.1 Church & Dwight Co., Inc (U.S.) Company Details

7.10.2 Description and Business Overview

7.10.3 Hormonal Contraceptive Introduction

7.10.4 Church & Dwight Co., Inc (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.10.5 Church & Dwight Co., Inc (U.S.) Recent Development

7.11 Organon group of companies (U.S.)

7.11.1 Organon group of companies (U.S.) Company Details

7.11.2 Description and Business Overview

7.11.3 Hormonal Contraceptive Introduction

7.11.4 Organon group of companies (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.11.5 Organon group of companies (U.S.) Recent Development

7.12 Reckitt Benckiser Group PLC (U.K.)

7.12.1 Reckitt Benckiser Group PLC (U.K.) Company Details

7.12.2 Description and Business Overview

7.12.3 Hormonal Contraceptive Introduction

7.12.4 Reckitt Benckiser Group PLC (U.K.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.12.5 Reckitt Benckiser Group PLC (U.K.) Recent Development

7.13 Veru Inc. (U.S.)

7.13.1 Veru Inc. (U.S.) Company Details

7.13.2 Description and Business Overview

7.13.3 Hormonal Contraceptive Introduction

7.13.4 Veru Inc. (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.13.5 Veru Inc. (U.S.) Recent Development

7.14 Boehringer Ingelheim International GmbH (Germany)

7.14.1 Boehringer Ingelheim International GmbH (Germany) Company Details

7.14.2 Description and Business Overview

7.14.3 Hormonal Contraceptive Introduction

7.14.4 Boehringer Ingelheim International GmbH (Germany) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.14.5 Boehringer Ingelheim International GmbH (Germany) Recent Development

7.15 Novartis AG (Switzerland)

7.15.1 Novartis AG (Switzerland) Company Details

7.15.2 Description and Business Overview

7.15.3 Hormonal Contraceptive Introduction

7.15.4 Novartis AG (Switzerland) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.15.5 Novartis AG (Switzerland) Recent Development

7.16 Lupin (India)

7.16.1 Lupin (India) Company Details

7.16.2 Description and Business Overview

7.16.3 Hormonal Contraceptive Introduction

7.16.4 Lupin (India) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.16.5 Lupin (India) Recent Development

7.17 Glenmark Pharmaceuticals (India)

7.17.1 Glenmark Pharmaceuticals (India) Company Details

7.17.2 Description and Business Overview

7.17.3 Hormonal Contraceptive Introduction

7.17.4 Glenmark Pharmaceuticals (India) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023)

7.17.5 Glenmark Pharmaceuticals (India) Recent Development

8 Industry Chain and Sales Channels Analysis

8.1 Hormonal Contraceptive Value Chain Analysis

8.2 Hormonal Contraceptive Key Raw Materials

8.2.1 Key Raw Materials

8.2.2 Distributors List

8.3 Hormonal Contraceptive Production Mode & Process

8.4 Hormonal Contraceptive Sales and Marketing

8.4.1 Magnetic Coupled Mixers Sales Channels

8.4.2 Magnetic Coupled Mixers Distributors

8.5 Magnetic Coupled Mixers Customers

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 A Methodology

10.1.1 Research Process

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 B Data Source

10.2.1 Legal Disclaimer

List of Tables and Figures

Figure Hormonal Contraceptive Product Picture

Table Global Hormonal Contraceptive Revenue, ($), 2018 VS 2023 VS 2029

Figure Global Hormonal Contraceptive Market Size 2018-2029 ($)

Table United States Hormonal Contraceptive Revenue, ($), 2018 VS 2023 VS 2029

Figure United States Hormonal Contraceptive Market Size 2018-2029 ($)

Figure United States Hormonal Contraceptive Market Share in Global, in Value 2018-2029

Table Hormonal Contraceptive CAGR in Value, United States VS Global, 2018 VS 2023 VS 2029

Table Hormonal Contraceptive Market Trends

Table Hormonal Contraceptive Market Drivers

Table Hormonal Contraceptive Market Challenges

Table Hormonal Contraceptive Market Restraints

Figure Hormonal Contraceptive Report Years Considered

Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021

Figure Population infected by the Covid-19 of Major Countries

Table Top Hormonal Contraceptive Players in Global Market, Ranking by Revenue (2023)

Table Global Hormonal Contraceptive Revenue by Player, ($), 2018-2023

Table Global Hormonal Contraceptive Revenue Share by Player, 2018-2023

Table Global Hormonal Contraceptive Players Market Concentration Ratio (CR5)

Figure The Top 3 and 6 Largest Players of Hormonal Contraceptive in the World: Market Share by Hormonal Contraceptive Revenue in 2023

Table Top Players of Hormonal Contraceptive in Global Market, Headquarters and Distribution

Table Players Hormonal Contraceptive Business Type

Table Date of International Players Enter into Hormonal Contraceptive Market

Table Players Mergers & Acquisitions, Expansion Plans

Table Top Hormonal Contraceptive Players in United States Market, Ranking by Revenue (2023)

Table United States Hormonal Contraceptive Revenue by Player, ($), 2018-2023

Table United States Hormonal Contraceptive Revenue Share by Player, 2018-2023

Table Global Hormonal Contraceptive Revenue by Type: 2023 VS 2029 ($)

Figure Global Hormonal Contraceptive Market Share by Type in 2023 & 2029

Figure Global Hormonal Contraceptive Revenue by Type (2018-2029) & ($)

Figure Global Hormonal Contraceptive Revenue Market Share in Value by Type (2018-2029)

Table United States Hormonal Contraceptive Revenue by Type: 2023 VS 2029 ($)

Figure United States Hormonal Contraceptive Market Share by Type in 2023 & 2029

Figure United States Hormonal Contraceptive Revenue by Type (2018-2029) & ($)

Figure United States Hormonal Contraceptive Revenue Market Share in Value by Type (2018-2029)

Table Global Hormonal Contraceptive Revenue by Application: 2023 VS 2029 ($)

Figure Global Hormonal Contraceptive Market Share by Application in 2023 & 2029

Figure Global Hormonal Contraceptive Revenue by Application (2018-2029) & ($)

Figure Global Hormonal Contraceptive Revenue Market Share in Value by Application (2018-2029)

Table United States Hormonal Contraceptive Revenue by Application: 2023 VS 2029 ($)

Figure United States Hormonal Contraceptive Market Share by Application in 2023 & 2029

Figure United States Hormonal Contraceptive Revenue by Application (2018-2029) & ($)

Figure United States Hormonal Contraceptive Revenue Market Share in Value by Application (2018-2029)

Table Global Hormonal Contraceptive Market Size by Region ($): 2018 VS 2023 VS 2029

Figure Global Hormonal Contraceptive Market Size Market Share by Region: 2018 VS 2023 VS 2029

Table Global Hormonal Contraceptive Revenue by Region (2018-2023) & ($)

Table Global Hormonal Contraceptive Revenue Forecast by Region (2023-2029) & ($)

Table Global Hormonal Contraceptive Revenue Market Share by Region (2018-2029)

Table Global Hormonal Contraceptive Volume by Region (2018-2023) & ($)

Table Global Hormonal Contraceptive Volume Forecast by Region (2023-2029) & ($)

Table Global Hormonal Contraceptive Volume Market Share by Region (2018-2029)

Figure North America Hormonal Contraceptive Revenue Growth Rate 2018-2029

Table North America Hormonal Contraceptive Revenue by Country (2018-2029) & ($)

Figure U.S. Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Canada Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Asia Pacific Hormonal Contraceptive Revenue Growth Rate 2018-2029 ($)

Table Asia Pacific Hormonal Contraceptive Revenue by Country (2018-2029) & ($)

Figure China Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Japan Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure South Korea Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure India Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Australia Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Southeast Asia Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Europe Hormonal Contraceptive Revenue Growth Rate 2018-2029 ($)

Table Europe Hormonal Contraceptive Revenue by Country (2018-2029) & ($)

Figure Germany Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure France Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure UK Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Italy Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Russia Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Latin America Hormonal Contraceptive Revenue Growth Rate 2018-2029 ($)

Table Latin America Hormonal Contraceptive Revenue by Country (2018-2029) & ($)

Figure Mexico Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Brazil Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Argentina Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Middle East and Africa Hormonal Contraceptive Revenue Growth Rate 2018-2029 ($)

Table Middle East and Africa Hormonal Contraceptive Revenue by Country (2018-2029) & ($)

Figure Turkey Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure Saudi Arabia Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Figure UAE Hormonal Contraceptive Revenue Growth Rate (2018-2029) & ($)

Table Abbvie, Inc (U.S.) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Abbvie, Inc (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Abbvie, Inc (U.S.) Recent Development

Table Afaxys, Inc. (U.S.) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Afaxys, Inc. (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Afaxys, Inc. (U.S.) Recent Development

Table Merck & Co Inc. (U.S.) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Merck & Co Inc. (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Merck & Co Inc. (U.S.) Recent Development

Table Teva Pharmaceuticals Industries Ltd. (Israel) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Teva Pharmaceuticals Industries Ltd. (Israel) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Teva Pharmaceuticals Industries Ltd. (Israel) Recent Development

Table Bayer AG (Germany) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Bayer AG (Germany) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Bayer AG (Germany) Recent Development

Table Pfizer Inc. (U.S.) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Pfizer Inc. (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Pfizer Inc. (U.S.) Recent Development

Table Agile Therapeutics (U.S.) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Agile Therapeutics (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Agile Therapeutics (U.S.) Recent Development

Table Cupid Ltd. (India) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Cupid Ltd. (India) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Cupid Ltd. (India) Recent Development

Table Helm AG (Germany) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Helm AG (Germany) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Helm AG (Germany) Recent Development

Table Church & Dwight Co., Inc (U.S.) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Church & Dwight Co., Inc (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Church & Dwight Co., Inc (U.S.) Recent Development

Table Organon group of companies (U.S.) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Organon group of companies (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Organon group of companies (U.S.) Recent Development

Table Reckitt Benckiser Group PLC (U.K.) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Reckitt Benckiser Group PLC (U.K.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Reckitt Benckiser Group PLC (U.K.) Recent Development

Table Veru Inc. (U.S.) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Veru Inc. (U.S.) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Veru Inc. (U.S.) Recent Development

Table Boehringer Ingelheim International GmbH (Germany) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Boehringer Ingelheim International GmbH (Germany) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Boehringer Ingelheim International GmbH (Germany) Recent Development

Table Novartis AG (Switzerland) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Novartis AG (Switzerland) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Novartis AG (Switzerland) Recent Development

Table Lupin (India) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Lupin (India) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Lupin (India) Recent Development

Table Glenmark Pharmaceuticals (India) Company Details

Table Description and Business Overview

Table Hormonal Contraceptive Introduction

Table Glenmark Pharmaceuticals (India) Hormonal Contraceptive Revenue, Sales, and Gross Margin (2018-2023) (Million USD)

Table Glenmark Pharmaceuticals (India) Recent Development

Figure Hormonal Contraceptive Value Chain

Table Key Raw Materials

Table Major Distributors of Hormonal Contraceptive with Contact Information

Table Research Process

Figure Bottom-up and Top-down Approaches for This Report

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)